ASX Announcement

Presentation of Exenatide Phase II Data at Headache Congress

Published: 29/06/20, 09:26am (AEST)2 pages
Invex Therapeutics Ltd
IXC:ASXHealthcare

Recent IXC Announcements

Price Sensitive only